Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/793524/000149315222006393/form10-k.htm
June 2022
June 2021
January 2021
December 2020
August 2020
August 2020
July 2020
June 2020
April 2020
January 2020
Cover - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 | Mar. 09, 2022 | Jun. 30, 2021 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Dec. 31, 2021 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2021 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 000-14893 | ||
Entity Registrant Name | RESEARCHFRONTIERS INCORPORATED | ||
Entity Central Index Key | 0000793524 | ||
Entity Tax Identification Number | 11-2103466 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Address, Address Line One | 240 CROSSWAYS PARK DRIVE | ||
Entity Address, City or Town | WOODBURY | ||
Entity Address, State or Province | NY | ||
Entity Address, Postal Zip Code | 11797-2033 | ||
City Area Code | 516 | ||
Local Phone Number | 364-1902 | ||
Title of 12(b) Security | Common Stock, $0.0001 Par Value | ||
Trading Symbol | REFR | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 65,419,119 | ||
Entity Common Stock, Shares Outstanding | 31,650,396 | ||
Auditor Firm ID | 596 | ||
Auditor Name | CohnReznick LLP | ||
Auditor Location | Melville, |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/793524/000149315222006393/form10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Research Frontiers Inc.
Research Frontiers Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Rating
Learn More![]()
Since the costs incurred to satisfy the Technical Support and New Improvements performance obligations are incurred evenly throughout the year, the value of the Technical Support and New Improvements services are recognized throughout the contract period as these performance obligations are satisfied.
The Company has primarily utilized its cash, cash equivalents, marketable securities, and proceeds from sales of our common stock, proceeds from the exercise of options and warrants, and royalty fees collected to fund its research and development, for marketing initiatives, and for other working capital purposes.
The Company expects to use its cash to fund its research and development of SPD light valves, its expanded marketing initiatives, and for other working capital purposes.
In addition, the Company incurred lower cash payroll and compensation costs ($243,000), as well as lower bad debts ($37,000), depreciation ($42,000) and investor relations costs ($19,000), partially offset by higher legal costs related to the collection efforts on outstanding royalties receivable ($136,000) and higher professional fees ($72,000).
Included in the lower payroll and related costs is lower non-cash compensation costs related to stock options granted to employees ($7,000) between the two periods.
Based on the royalty rate...Read more
The disruption caused by public...Read more
The disruption caused by COVID-19...Read more
This decrease was the result...Read more
The decrease was the result...Read more
The difference was due to...Read more
The Company expects to generate...Read more
Production efficiencies are expected to...Read more
During 2021, the Company's cash...Read more
Revenues were negatively impacted in...Read more
The Company determined that its...Read more
Operating expenses decreased by $255,686...Read more
Because the Company's license agreements...Read more
The Company applied for and...Read more
Higher fee income in the...Read more
The eventual success of the...Read more
The Company's working capital and...Read more
There can be no assurances...Read more
In addition to these macro...Read more
No income tax benefit or...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Research Frontiers Inc provided additional information to their SEC Filing as exhibits
Ticker: REFR
CIK: 793524
Form Type: 10-K Annual Report
Accession Number: 0001493152-22-006393
Submitted to the SEC: Wed Mar 09 2022 4:00:41 PM EST
Accepted by the SEC: Wed Mar 09 2022
Period: Friday, December 31, 2021
Industry: Patent Owners And Lessors